Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) CEO Brian Mckelligon sold 7,500 shares of the stock in a transaction dated Tuesday, June 11th. The shares were sold at an average price of $2.08, for a total value of $15,600.00. Following the completion of the sale, the chief executive officer now owns 224,733 shares of […]
Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) CEO Brian Mckelligon sold 7,500 shares of the company’s stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $2.08, for a total value of $15,600.00. Following the transaction, the chief executive officer now directly owns 224,733 shares […]
KPP Advisory Services LLC boosted its stake in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 17.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 11,196 shares of the company’s stock after purchasing an additional 1,675 shares during the quarter. KPP Advisory Services LLC’s […]
Sirios Capital Management L P lessened its position in CyberArk Software Ltd. (NASDAQ:CYBR – Free Report) by 9.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,708 shares of the technology company’s stock after selling 1,181 shares during the period. Sirios Capital Management L P’s […]
Sectoral Asset Management Inc. cut its position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 94.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 7,420 shares of the biopharmaceutical company’s stock after selling 116,260 shares during the period. Sectoral Asset Management Inc.’s holdings […]